Target intelligence / Profile preview

SRY-box transcription factor 2 (SOX2) promoter G-quadruplex and i-motif region (SOX2 promoter G4/i-motif)

Target
SOX2 promoter G4/i-motif
Molecular classification
Nucleic acid, Non-canonical DNA structure, Gene promoter element
01

Overview

The SRY-box transcription factor 2 (SOX2) promoter contains a nuclease hypersensitive element (NHE) with a G-rich sequence homologous to the c-MYC Pu27 region, which is capable of folding into G-quadruplex (G4) structures (Source: Scientific Reports 2017;7:10138). The complementary C-rich strand of this region can also form i-motif structures, which serve as additional regulatory switches for gene expression (Source: Bioorg Med Chem Lett 2018;28:1518). These non-canonical DNA structures play a critical role in regulating the transcription of SOX2, a master transcription factor essential for maintaining the pluripotency and self-renewal of embryonic and cancer stem cells (Source: UniProt P48431). SOX2 is frequently overexpressed in aggressive malignancies, including glioblastoma and lung cancer, where it drives tumor progression and resistance to therapy (Source: PubMed 28844886). Small molecule ligands that stabilize these G4 or i-motif structures can effectively downregulate SOX2 expression, offering a therapeutic strategy to target cancer stemness and overcome chemoresistance (Source: Nucleic Acids Res 2014;42:7422). However, achieving high selectivity for the SOX2-specific sequence over other genomic G-quadruplexes remains a significant challenge in drug development (Source: PubMed 30245445).

Other names
SOX2 promoter Pu27-homologous regionSOX2 G-quadruplexSOX2 i-motifSOX2 nuclease hypersensitive elementSOX2 NHE
02

Mechanism of action

Stabilization of G-quadruplex or i-motif structures within the SOX2 promoter to sterically hinder transcription factor binding and RNA polymerase recruitment, leading to transcriptional repression of the SOX2 gene.

03

Biological functions

Regulation of transcriptionStem cell maintenancePluripotencyCell self-renewal
04

Disease associations

CancerGlioblastomaSmall cell lung cancerBreast cancerCancer stemness
05

Safety considerations

Off-target binding to other genomic G-quadruplexesPotential systemic toxicityInterference with normal stem cell functionActivation of DNA damage response
06

Interacting drugs

TMPyP4

6 more in the full profile.

07

Biomarkers

SOX2 mRNA expression levelsSOX2 protein levelsCD133 expressionALDH1 activity

Beyond the preview

Go deeper on SRY-box transcription factor 2 (SOX2) promoter G-quadruplex and i-motif region (SOX2 promoter G4/i-motif).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SRY-box transcription factor 2 (SOX2) promoter G-quadruplex and i-motif region (SOX2 promoter G4/i-motif).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call